Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (56)

Latest Posts

About This Stock More About This Stock
Allergan Takes Legal Action Against Another Restasis Competitor
Article By: Shock Exchange
Thursday, September 21, 2017 11:15 AM EDT
Allergan has dominated the financial news cycle since it agreed to sell its Restasis patents to St. Regis Mohawks in order to protect them.
In this article: AGN Also: IMMY, MYL, MS, SHPG, PFE, TEVA
Read
Allergan: Growth Is Dead
Article By: Shock Exchange
Wednesday, August 23, 2017 4:19 PM EDT
Allergan is another healthcare company that grows via acquisition. Q2 revenue and EBITDA grew Y/Y by 9% and 12%, respectively. Declining revenue growth for generics and a high price tag for Zeltiq are causes for concern. Growth appears dead at AGN.
In this article: AGN Also: MNK, VRX
Read
Allergan Signals Higher Prices Potentially Ahead For Teva Pharmaceuticals
Article By: Dr. Duru
Tuesday, August 8, 2017 4:28 AM EDT
Teva Pharmaceuticals (TEVA) lost 24% last Thursday after reporting disappointing earnings. Investors clearly had no patience for any of this news.
In this article: AGN, MYL, TEVA
Read
Teva Q2 Earnings Lag, '17 View & Dividend Cut, Stock Slumps
Article By: Zacks Investment Research
Friday, August 4, 2017 7:38 AM EDT
Shares declined 24% on Thursday, hitting a 52-week low of $23.33 per share. In fact, shares have slumped 34.5% so far this year compared with the industry’s decline of 1.9%.
In this article: TEVA, NVS, AGN, MYL
Read
Yum! Brands, Inc. Q2 2017, Allergan Plc Q2 2017 Earnings Reported
Article By: ValueWalk
Thursday, August 3, 2017 8:56 AM EDT
Yum! Brands Q2 2017 earnings and Allergan Q2 2017 earnings were released before opening bell this morning.
In this article: YUM, AGN
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 1 of 1 comments